These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33867420)

  • 21. Study design and rationale of "Synergistic effect of combination therapy with cilostazol and ProbUcol on plaque stabilization and lesion REgression (SECURE)" study: a double-blind randomised controlled multicenter clinical trial.
    Ko YG; Kim BK; Lee BK; Kang WC; Choi SH; Kim SW; Lee JH; Lee M; Honda Y; Fitzerald PJ; Shim WH;
    Trials; 2011 Jan; 12():10. PubMed ID: 21226953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Evidence of Probucol on Cardiovascular Events.
    Hirata KI
    J Atheroscler Thromb; 2021 Feb; 28(2):97-99. PubMed ID: 33229816
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events.
    Tada H; Nakagawa T; Okada H; Nakahashi T; Mori M; Sakata K; Nohara A; Takamura M; Kawashiri MA
    J Atheroscler Thromb; 2020 Jan; 27(1):38-46. PubMed ID: 31105127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probucol alleviates atherosclerosis and improves high density lipoprotein function.
    Zhong JK; Guo ZG; Li C; Wang ZK; Lai WY; Tu Y
    Lipids Health Dis; 2011 Nov; 10():210. PubMed ID: 22078494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.
    Frerix M; Stegbauer J; Kreuter A; Weiner SM
    Arthritis Res Ther; 2014 Feb; 16(1):R54. PubMed ID: 24548804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Lee YJ; Daida H; Yokoi H; Miyano H; Takaya J; Sakurai H; Mokuno H; Yamaguchi H
    Jpn Heart J; 1996 May; 37(3):327-32. PubMed ID: 8774625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin.
    Keyamura Y; Nagano C; Kohashi M; Niimi M; Nozako M; Koyama T; Yasufuku R; Imaizumi A; Itabe H; Yoshikawa T
    PLoS One; 2014; 9(5):e96929. PubMed ID: 24810608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
    Kim G; Youn HJ; Choi YS; Jung HO; Chung WS; Kim CM
    Clin Interv Aging; 2015; 10():1111-9. PubMed ID: 26185430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inter-individual blood pressure variability on the progression of atherosclerosis in carotid and coronary arteries: a post hoc analysis of the NORMALISE and PREVENT studies.
    Kim JS; Park S; Yan P; Jeffers BW; Cerezo C
    Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):82-89. PubMed ID: 27533954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
    Nonin S; Iwata S; Sugioka K; Fujita S; Norioka N; Ito A; Nakagawa M; Yoshiyama M
    Atherosclerosis; 2017 Jan; 256():29-34. PubMed ID: 27998824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia.
    Kajinami K; Nishitsuji M; Takeda Y; Shimizu M; Koizumi J; Mabuchi H
    Atherosclerosis; 1996 Feb; 120(1-2):181-7. PubMed ID: 8645359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease.
    Watanabe K; Sugiyama S; Kugiyama K; Honda O; Fukushima H; Koga H; Horibata Y; Hirai T; Sakamoto T; Yoshimura M; Yamashita Y; Ogawa H
    J Am Coll Cardiol; 2005 Dec; 46(11):2022-30. PubMed ID: 16325036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study.
    Kurabayashi M; Sakuma I; Kawamori R; Daida H; Yamazaki T; Yoshida M; Hata M; Masuda I; Kaku K; Yokoi H; Kishimoto J; Nohara R
    J Atheroscler Thromb; 2010 Apr; 17(4):416-22. PubMed ID: 20215710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial.
    Tanaka A; Taguchi I; Teragawa H; Ishizaka N; Kanzaki Y; Tomiyama H; Sata M; Sezai A; Eguchi K; Kato T; Toyoda S; Ishibashi R; Kario K; Ishizu T; Ueda S; Maemura K; Higashi Y; Yamada H; Ohishi M; Yokote K; Murohara T; Oyama JI; Node K;
    PLoS Med; 2020 Apr; 17(4):e1003095. PubMed ID: 32320401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of probucol, aspirin and atorvastatin combination therapy upon atherosclerosis].
    Meng XP; Wang SX; Zhang JC; Li ZX; Geng L; Yin CY
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1986-8. PubMed ID: 19950575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis.
    Gepner AD; Young R; Delaney JA; Tattersall MC; Blaha MJ; Post WS; Gottesman RF; Kronmal R; Budoff MJ; Burke GL; Folsom AR; Liu K; Kaufman J; Stein JH
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection.
    Sawayama Y; Tatsukawa M; Kikuchi K; Maeda S; Ohnishi H; Furusyo N; Hayashi J
    J Infect Chemother; 2007 Apr; 13(2):92-8. PubMed ID: 17458676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carotid atherosclerotic disease predicts cardiovascular events in hemodialysis patients: a prospective study.
    Collado S; Coll E; Nicolau C; Pons M; Cruzado JM; Pascual J; Cases A
    PLoS One; 2015; 10(6):e0127344. PubMed ID: 26029907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined effect of atorvastatin and probucol on plasma cystatin C levels and severity of coronary lesion in patients with borderline coronary lesion.
    Ge CJ; Lü SZ; Feng LX; Huo Y; Song XT; Chen X; Meng K; Yuan F
    Chin Med J (Engl); 2012 Jul; 125(14):2472-6. PubMed ID: 22882924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort.
    Polak JF; Backlund JC; Budoff M; Raskin P; Bebu I; Lachin JM;
    J Am Heart Assoc; 2021 Dec; 10(24):e022922. PubMed ID: 34873921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.